Biomica Ltd., a clinical-stage biopharmaceutical company, has announced promising interim results from pre-clinical studies in its Irritable Bowel Syndrome (IBS) program. The findings demonstrate the effectiveness of Biomica's live bacterial consortia, BMC426 and BMC427, in alleviating symptoms commonly associated with IBS, such as abdominal pain and abnormal bowel movements. These positive outc..
BioCryst Pharmaceuticals, Inc. has joined forces with Er-Kim Pharmaceuticals to bring ORLADEYO® (berotralstat) to the Turkish market, in line with their mission to provide access to the medication for patients worldwide. Er-Kim's expertise in delivering innovative therapies to patients with unmet medical needs makes them an ideal partner for BioCryst. ORLADEYO is a groundbreaking oral therapy sp..
Teleflex Completes Enrollment in Percutaneous Coronary Intervention Study Teleflex Incorporated, a leading global provider of medical technologies, has announced the successful completion of patient enrollment in the RingerTM PTCA study. This groundbreaking study is one of two clinical trials that aim to evaluate the performance and effectiveness of the innovative RingerTM Perfusion Balloon Cath..
VBI Vaccines Inc. (Nasdaq: VBIV) has announced the availability of PreHevbri® [Hepatitis B vaccine (recombinant, adsorbed)] in the Netherlands and Belgium for active immunization against all known subtypes of the hepatitis B virus (HBV) in adults. The vaccine will be launched in partnership with Valneva, their marketing and distribution partner. PreHevbri® is currently the only approved 3-antige..
Hoth Therapeutics, a biopharmaceutical company focused on patient care, has recently received protocol approval for its cancer therapeutic, HT-001. This exciting development was announced on July 19, 2023.   The FDA-approved trial now has two sites approved for conducting the study, and additional sites are currently in the approval process. This means that recruitment of patients can now be..
Reveal Lasers LLC, a subsidiary of Reveal Lasers LTD, has recently completed a strategic merger with NEOconcepts LLC, resulting in the acquisition of the AgeJET Advanced Plasma Skin Therapy device. This milestone marks an important step for Reveal Lasers LLC as it expands its presence in the rapidly growing market of plasma skin resurfacing.   Renowned for its cutting-edge technology and exc..
Inspira™ Technologies, a company dedicated to transforming acute respiratory care, has recently formed a collaboration agreement with Perfusion Solution, Inc. This U.S.-based company is known for its advanced medical devices, training, and staffing services provided to top hospitals in the country.   Under this partnership, Inspira Technologies will be combining their innovative INSPIRA™ ART..
